INTRODUCTION
The secretory granules of adrenal medullary chromaffin cells synthesize, store and then liberate catecholamines by exocytosis after cell stimulation with acetylcholine, itself liberated from the splanchnic nerve (for review, see Viveros, 1975) .
Apart from adrenaline and noradrenaline, chromaffin granules contain a great number of molecules, essentially proteins, which are co-secreted with the catecholamines. The soluble acidic proteins of chromaffin granules have been collectively called chromogranins (Blaschko et al., 1967) . Chromogranin A (CGA) is the major protein, representing 40 % of the soluble protein ofbovine adrenal medullary chromaffin granules (Winkler, 1976) . Since it was first characterized about 20 years ago (Helle, 1966) , CGA has been much studied. Its physicochemical properties have been analysed in detail. However, it was only in 1986 that two independent groups obtained for the first time the complete primary sequence of CGA of the bovine chromaffin granule (Benedum et al., 1986; Iacangelo et al., 1986) . The recent discovery of a negative feedback control of insulin and catecholamine (Simon et al., 1988) release by peptide derivatives of CGA and the presence of an anti-CGA immunoreactivity in numerous endocrine and nervous tissues, support the concept that this protein might have a major function in the maintenance of physiological equilibria of organisms. This article summarizes the work of 20 years of research on CGA of bovine chromaffin cells and those of other species. Recent data showing that CGA is not restricted to chromaffin cells but is also present in numerous other endocrine and neuroendocrine -cells will be analysed and discussed. Finally, the value of CGA to pathology in the diagnosis of certain types of neuroendocrine tumours will be mentioned.
CHROMOGRANIN A OF BOVINE ADRENAL MEDULLARY CHROMAFFIN CELLS

Structural properties
CGA of bovine chromaffin granules is a protein of molecular mass between 70 and 75 kDa, as shown by analytical ultracentrifugation (Smith & Winkler, 1967) or by SDS gel electrophoresis (Winkler, 1976) . Determination of the primary sequence of CGA by Benedum et al. (1986) and Iacangelo et al. (1986) however permits the attribution of a real molecular mass of 48 kDa (Fig. 1) . Taking into account post-translhtional modifications, this value corresponds to that (53 kDa) obtained by Kirshner (1974) using the equilibrium sedimentation method in the presence of guanidine hydrochloride. Thus, the molecular mass of CGA calculated from its primary sequence gives a value considerably less than that determined by polyacrylamide-gel electrophoresis in the presence of SDS. Translation of CGA mRNA in vitro gives a protein which migrates, under denaturing conditions, as a component of 75 kDa. CGA is thus a protein with a real molecular mass close to 50 kDa but which migrates in SDS gel electrophoresis with an apparent molecular mass of 75 kDa. This difference between apparent and real molecular mass of CGA might result from the weak binding of SDS to the protein, thus considerably reducing its migration rate. Benedum et al. (1986) and lacangelo et al. (1986) succeeded, thanks to molecular cloning techniques, in obtaining a cDNA clone to CGA. The cDNA clone hybridizes to a mRNA of 2100 bases. The total length of the mRNA, without taking into account its poly(A) tail, is 1881 bases according to Benedum et al. (1986) or 1929 bases according to lacangelo et al. (1986) . The open reading frame codes for a protein of 449 amino acids (Fig. 1) . The first 18 amino acid residues constitute the signal sequence responsible for the targeting and the passage of the nascent polypeptide to and through the membrane of rough endoplasmic reticulum. After cleavage of the signal sequence, the CGA polypeptide chain comprises 431 amino acids, corresponding to an unmodified protein of 48 kDa.
The amino acid composition of the protein coded by the CGA cDNA clone is in agreement with that deduced from the cDNA nucleotide sequence. Its amino acid composition is unusual in that it has a high content (24.1 %) of acidic amino acids. These values are in perfect agreement with data on amino acid composition previously reported (for references, see Winkler, 1976) . In addition, analysis of the CGA sequence does not support the data of Settleman et al. (1985b) on amino acid sequence homologies within the CGA molecule. While the glutamic acid residues are present all along the CGA sequence, they are preferentially grouped in several regions of the molecule. The high density of negative charges confers an acidic isoelectric pH of 4.5-5.0 on CGA. CGA is, on the other hand, a protein rich in proline (about 10%) and cysteine is particularly rare: only three cysteine residues, localized in the first 60 amino acids, are present (Fig. 1) .
In 1967, Smith & Winkler noted 
Comparison of amino acid sequences of bovine, human, rat and porcine chromogranin A, bovine secretory protein I, porcine pancreastatin and human pancreastatin-like peptide bCGA and bCGA' are the bovine chromogranin A sequences as reported by lacangelo et al. (1986) and by Benedum et al. (1986) respectively; hCGA and hCGA' are the human chromogranin A sequences as reported by Konecki et al. (1987) and by Helman et al. (1988) respectively; rCGA, rat chromogranin A sequence (lacangelo et al., 1988a) ; pCGA, porcine chromogranin A sequence (lacangelo et al., 1988b) ; bSPI, bovine secretory protein I sequence (Ahn et al., 1987) ; rBEG, rat f-granin sequence (Hutton et al., 1988) ; pPAN, porcine pancreastatin sequence ; hPLP, human pancreastatin-like peptide sequence (Sekiya et al., 1988 unusual behaviour of CGA on gel filtration chromatography has recently been confirmed (Fischer-Colbrie & Frischenschlager, 1985; Simon et al., 1988) ; the protein is consistently eluted in fractions containing proteins of molecular masses several times higher (300-400 kDa) than that determined using other techniques. In fact, these results are explained by the special tertiary structure of CGA approaching that of a 'random coil polypeptide', an hypothesis that studies in vitro and in vivo by nuclear magnetic resonance have confirmed (Daniels et al., 1978) .
The relatively large spatial volume occupied by the molecule may be attributed to electrostatic repulsion of the numerous negative charges. The predicted secondary structure of CGA, based on the primary sequence, supports this model (Grimes et al., 1987) . It is possible that the molecule has a few a-helix-forming regions; however, the groups of amino acid residues that might form an a-helix structure are made up of many residues with the same charge (mostly glutamic acid) which would oppose the formation of a stable ac-helix. In addition, the ,f-sheet percentage content in CGA molecule is very low.
Analysis of the primary structure of CGA in terms of secondary and tertiary structures shows that this protein is not globular but possesses a disorganized structure termed 'random coil'.
CGA is a glycoprotein containing 5.40 carbohydrate (Kiang et al., 1982; Apps et al., 1985) . Methylation and specific sugar degradation have shown the protein to be associated through O-glycosidic linkages with tri-and tetra-saccharides constituted of galactose, N-acetylgalactosamine and sialic acids. CGA does not seem to be N-glycosylated since tunicamycin, an N-glycosylation inhibitor, has no effect on sugar chain synthesis (Rosa et al., 1985) . CGA does not bind to concanavalin A nor other mannose-or galactose-specific lectins. However, treatment of CGA with neuraminidase enables the protein to bind galactose-specific but not mannose-specific lectins. Galactose is'situated in the penultimate position in CGA sugar chains. As shown by the primary structure of CGA, potential O-glycosidic (serine and threonine residues) binding sites are present all along the molecule. It is thus impossible to predict which are O-glycosylated. On the other hand, studying the primary sequence reveals no possibility of N-glycosylation (Kornfeld & Kornfeld, 1985) . These data are in agreement with biochemical analyses (Kiang et al., 1982 (Falkensammer et al., 1985a) , an observation confirmed by Rosa et al. (1985) who, in addition, showed that sulphate is bound to O-glycans and not to tyrosine residues as is frequently the case. Secreted proteins bear sulphated tyrosine residues when these are preceded mostly by acidic amino acids . None of the four tyrosine residues of CGA are preceded by such amino acids.
The chromogranin A stored in the secretory granules of chromaffin cells maintained in primary culture, and subsequently secreted, is a carboxymethylated protein (Nguyen et al., 1987) . Since carboxymethylase is localized exclusively in the cytosol of chromaffin cells (Diliberto et al., 1976) , CGA methylation is a co-translational phenomenon. Bovine erythrocyte carboxymethylase incorporates 660 pmol of methyl groups per mg of CGA in 10 min. The stoichiometry of CGA methylation in vitro is 0.26 mol of methyl groups per mol of protein (Veeraragavan et al., 1988) . The biological significance of CGA methylation is at the moment unknown.
Binding capacity
From experiments with specific dyes for calciumbinding proteins and labelling with 45Ca, CGA appears to be a 'calci-protein' (Reiffen & Gratzl, 1986a,b) . CGA binds intragranular calcium with a weak affinity but with a high capacity (Reiffen & Gratzl, 1986b (Gratzl, 1987) . Analysis of the CGA primary sequence shows that this contains regions specific to calcium-binding proteins (lacangelo et al., 1986) .
Electrostatic interactions between soluble acidic proteins and ATP have been observed by nuclear magnetic resonance in chromaffin granules (Daniels et al., 1978; Sharp & Sen, 1979) . Similar interactions exist between CGA and catecholamines (Uvnas & Aborg, 1977 . However, the latter results should be treated with caution, and further data with purified CGA are necessary to confirm these conclusions.
Helle postulated that CGA is the major protein of the chromaffin granule membrane (Helle & Serck-Hanssen, 1969; Helle, 1971) . In contrast, Winkler et al. (1970) found very little in their preparations of membrane granules. However, more recently Settleman et al. (1985a) have again raised the question of intragranular CGA localization by stating that CGA is not only a soluble protein but is also a constitutive protein of the granule membrane. Nevertheless, two observations tend to contradict their results: (1) CGA is found exclusively in the aqueous phase when membranes are treated with Triton-X1 14 while intrinsic membrane proteins such as dopamine /J-hydroxylase or cytochrome b561 remain in the organic phase (Pryde & Phillips, 1986) ; (2) ultrastructural immunocytochemistry demonstrates that only the soluble component ofchromaffin granules reacts with anti-CGA serum (Aunis et al., 1980 ; see also Ehrhart et al., 1986 ). It appears that the extraction and washing procedures employed by Settleman et al. (1985a) were inadequate to remove soluble CGA adsorbed to membranes during subcellular fractionation and granule lysis.
Apart from the signal sequence, CGA is an extremely hydrophilic protein. This hydrophilic nature enables the protein to remain soluble after boiling (Rosa et al., 1985) . Hydrophobicity tests have shown that CGA lacks significant hydrophobic regions.
Vol. 262 3 Biosynthesis
To study CGA biosynthesis in vitro, mRNAs were isolated from bovine adrenal medulla and translated in a cell-free wheat germ system (Kilpatrick et al., 1983; Falkensammer et al., 1985b) or in rabbit reticulocyte lysates (Falkensammer et al., 1985b) . In both systems, two components are immunoprecipitated by anti-CGA sera. These two polypeptides of apparent molecular masses 73 kDa and 75 kDa have slightly different isoelectric pH values from endogenous CGA. In the presence of microsomes, these two precursors are converted to a protein of 72 kDa by removal of two signal sequences each with a different length. The relation between the two CGA precursor polypeptides is not yet established. The suggestion that these two precursors result from the initiation of the translation at different AUG codons of a single mRNA or two CGA mRNAs has not been confirmed by data on the translation in vitro of the mRNA of 2100 bases (Benedum et al., 1986; lacangelo et al., 1986 These results seem to indicate that for CGA in cultured chromaffin cells, no coupling exists between stimulus, secretion and synthesis. However, the biosynthetic regulation of CGA in chromaffin cells in primary culture has been recently examined (Simon et al., 1989) by measuring CGA synthesis after radioactive amino acid incorporation and subsequent immunoprecipitation. It appears that in fact the rate of CGA synthesis is directly related to.the secretory activity of the cells. Cellular stimulation by secretagogues activates CGA synthesis. This activation is calcium-dependent and it is known that the calcium is derived from the external medium (Artalejo et al., 1987) . It may be concluded that the decrease of intracellular CGA level due to secretion is compensated by an increased synthesis in order, so it seems, to maintain constant intracellular CGA levels. Such conclusions disagree with those of Eiden and co-workers, but, since CGA is easily degraded in the extracellular medium (Simon et al., 1988) , the technique employed by Eiden and co-workers may in fact underestimate the amount of released CGA.
While forskolin does not alter the synthetic rate of CGA (Eiden et al., 1987a; Simon et al., 1989) , 12-0-tetradecanoylphorbol 13-acetate (TPA), a protein kinase C activator, increases it significantly (Simon et al., 1989) . The increase in CGA synthesis induced by phorbol ester probably results from protein kinase C activation. This conclusion is supported by the observation that sphingosine, a protein kinase C inhibitor, prevents the increase in CGA synthesis provoked by nicotine stimulation of cells.
Thus, the synthesis of CGA of bovine chromaffin granules appears to be regulated, at least in part, by protein kinase C, though the intracellular message has not yet been identified. Since CGA mRNA levels remain constant in primary chromaffin cell cultures, even after cell stimulation (Waschek et al., 1987) , protein kinase C might regulate CGA synthesis in normal cells at a translational step. Evidence for and characterization of a family of chromogranin A Anti-CGA sera, obtained by injecting animals with native CGA purified from secretory granules, react not only with this molecular form but also with other proteins and polypeptides which are also present in secretory granules (Fig. 2 ). This observation was described for the first time by Hortnagl et al. in (Ehrhart et al., 1986; Grube et al., 1986; Eiden et al., 1987a; Simon et al., 1988) .
Biochemistry of chromogranin A A diffuse component with a heterogenous pI (4.0-5.0) and high apparent molecular mass (85-100 kDa) is specifically recognized by anti-CGA antibodies (Kilpatrick et al., 1983; Rosa et al., 1985; J.- 
Aunis, unpublished work: Fig. 2 ). This component is actually a proteoglycan (proteoglycan-CGA; for proposed nomenclature see Eiden et al., 1987b) , the nature of which has been elucidated by radioactive labelling and selective digestion with chondroitinase ABC. The glycan chain consists of chondroitin 4,6-sulphate and dermatan sulphate which represent respectively about 25 and 500 of the total carbohydrates (Kiang et al., 1982) . Little is known about the core protein of this proteoglycan. The amino acid composition is similar to that of CGA (Kiang et al., 1982) though the peptide maps are quite different (Banerjee & Margolis, 1982) suggesting that the proteoglycan protein core is structurally distinct from CGA in spite of certain similarities of the two molecules. The function of the proteoglycan-CGA is at present unknown, although an intragranular role as a condensing factor might be suggested.
Anti-CGA sera recognize proteins of molecular mass lower than that of CGA. The various antisera recognize between five and nine molecular species of molecular species of molecular masses respectively between 43 and 74 kDa (Simon et al., 1988) and between 17.4 and 75 kDa (Kilpatrick et al., 1983; Fischer-Colbrie & Frischenschlager, 1985) . This diversity of results can be explained by the variability of epitopes recognized by each antiserum. All proteins recognized by anti-CGA antibodies are characterized by very similar isoelectric points; however, CGA-generated peptides with molecular mass lower than 17.4 kDa do not cross-react with anti-CGA antibodies due to the loss of epitopes. In 1976, Winkler suggested that polypeptides recognized specifically by anti-CGA antibodies are degradation products of CGA, which are present in vivo in chromaffin granules. Results of studies on CGA biosynthesis in vitro have refuted the suggestion that these species derive from the same gene family. CGA represents about 53 % of total CGA immunoreactive protein of the chromaffin granule (Hagn et al., 1986b; Simon et al., 1988) . When the anti-CGA immunoreactivity of various fractions obtained by centrifugation of a crude granule preparation on a 1.0-2.2 M continuous sucrose gradient (J. P. Simon & D. Aunis, unpublished work) is tested, a homogeneous distribution of CGA and its degradation products is found in all fractions. This result appears to indicate that CGA is co-stored with its degradation products and that immunoreactive species are present in the same ratios in both immature and mature granules. The CGA molecules would thus appear to be cleaved early in vivo. The same ratio is, in addition, found for the extracellular fraction after cell stimulation (J. P. Simon & D. Aunis, unpublished work). Studies of cellular CGA synthesis appear, however, to indicate that the moelcule is not processed proteolytically immediately after its synthesis. In fact, after a 2 h chase period, degradation products resulting from newly synthesized CGA cannot be detected in granules (Falkensammer et al., 1985b) . Most recent data appear to show that CGA is still undegraded 18-20 h after its biosynthesis (Phillips, 1987; Simon et al., 1989) . Apparently endogenous CGA degradation is a slow process. CGA appears to be continually degraded into polypeptides of lower molecular mass until it is secreted, although the mechanisms which control CGA degradation are not known at the present time.
Examination of the sequence of CGA reveals the presence of eight pairs of basic amino acids, six of which are found in the C-terminal region of the molecule (Benedum et al., 1986; lacangelo et al., 1986) . Each pair of basic amino acids represents a potential cleavage site for trypsin-like endoproteases (Fig. 1) . The endogenous CGA degradation products might arise from cleavage of the molecule at such sites. Given the random coil conformation of the protein and its degradation products, it is difficult to compare the sizes of endogenous immunoreactive proteins and polypeptides with those predicted by the sequence of CGA. Nevertheless, a relatively close correlation exists between native CGA and theoretically possible polypeptides and those found in vivo, on the basis that CGA is cleaved sequentially at dibasic amino acid sites starting from the C-terminal end .
The production of antibodies directed against synthetic CGA peptides should afford unambiguous conclusions on whether dibasic amino acid pairs are really the cleavage sites in vivo. Other types of cleavage sites cannot be excluded, in particular those close to serine residues. In fact, Wohlfarter et al. (1988) have shown with sera directed against synthetic peptides present in the bovine CGA sequence that intragranular degradation of native CGA into sub-species could start at cleavage sites at either the N-terminal or C-terminal ends.
It is reasonable to suppose that native CGA is degraded in the chromaffin granule; this degradation should be due to specific proteases present in the chromaffin granule matrix. However, very little is known at the moment on the nature of these proteases. The presence of several enzymes with peptidase activity has been demonstrated in chromaffin granules. These enzymes are involved in the process of transforming enkephalin precursors (proenkephalins) into enkephalins. These are essentially endopeptidases, including the serine proteases (Linberg et al., 1984) , with trypsin-like activity (Evangelista et al., 1982) and exopeptidases with carboxypeptidase activity (Hook et al., 1982; Fricker & Snyder, 1982) . The involvement of such intragranular enzymes in CGA degradation and the formation of the CGA family are not yet established.
An enzyme likely to cleave CGA has been recently identified: it is acetylcholinesterase (AChE; EC 3.1.1.7). Its activity is detectable in the matrix and the membrane of chromaffin granules (Somogyi et al., 1975; Gratzl et al., 1981; Burgun et al., 1986) . Recent data have shown that, apart from its esterase activity, AChE has the capacity to hydrolyse peptide bonds (Chubb et al., 1980 (Chubb et al., , 1983 Chubb & Millar, 1984; Ismael et al., 1986 degraded in chromaffin granules by a calcium-dependent mechanism, but unfortunately this result has not been confirmed. Three hypotheses may be advanced on the timing of the appearance of CGA breakdown products: (1) CGA is degraded immediately after its synthesis by proteases not necessarily present in chromaffin granule; (2) CGA is degraded in immature granules by intragranular proteolytic enzymes, the activity of which might depend on intra-or extragranular factors yet to be characterized; (3) CGA is continually degraded from the time of its synthesis to its liberation into the extracellular medium by a slow process. Only detailed studies in which the appearance of CGA breakdown products are analysed in conjunction with the biogenesis of the chromaffin granule will confirm one or other of the hypotheses.
Functions of chromogranin A
The soluble compartment of each mature secretory granule contains more than a dozen different molecular species (Winkler & Westhead, 1980) including CGA (5000 molecules per granule), nucleotide triphosphates (930 000 molecules ofATP) and catecholamines (3 000 000 molecules). In spite of hyperosniotic concentrations of hydrophilic molecules, the chromaffin granule is a system in osmotic equilibrium with its surrounding cytoplasm (Blaschko et al., 1956) .
What is the mechanism by which this iso-osmolarity is maintained ? Helle et al. (1985) postulated that the CGA family contributes to the regulation of osmotic pressure in chromaffin granules by interacting with other intragranular constituents. The experiments reported by these authors were performed by directly measuring the osmotic pressure exerted by the soluble phase of the granule. Since no study has been performed with purified CGA or the CGA family, it would be premature to suggest that CGA and its degradation products control the osmotic equilibrium between the granule and the cytosol. Nevertheless, even if CGA has no specific role in binding catecholamines, it might have a function in stabilizing granule contents, as suggested by Sharp & Sen (1979) .
CGA is able to bind calcium (Reiffen & Gratzl, 1986a,b) . This affinity for calcium might be partly responsible for the low amounts of free calcium in the chromaffin granule (4 mM), even though the total intragranular calcium concentration is 40 mM. Chromaffin granules could play an important role in decreasing cytosolic calcium (Kostron et al., 1977) . Stimulation of bovine chromaffin cells with secretagogues provokes a massive entry ofextracellular calcium into the cell interior (Kao & Schneider, 1986; Artalejo et al., 1987) . After stimulation, the intracellular free calcium concentration very quickly returns to basal levels and chromaffin granules may be in part responsible for the rapid sequestration of cytosolic calcium. Intragranular binding of calcium might be assured by CGA.
Recently, data have been reported on a role of CGA as a prohormone. It appears that peptides resulting from the breakdown of native CGA are able to inhibit the secretion of chromaffin cells in primary culture (Simon et al., 1988) . CGA and its degradatin products were purified from the soluble fraction ofchromaffin granules. This CGA family (CGAF) was found to inhibit nicotineinduced secretion, but only if cells had been preincubated with CGAF for about 60min. The fact that preincubation is a prerequisite for the inhibitory capacity of the CGAF and the observation that the ratio between CGA and its immunoreactive degradation products is modified during this preincubation step suggest that the CGAF-derived peptides rather than the CGAF are involved in inhibiting secretion. This has been unambiguously demonstrated with peptides obtained by trypsinolysis of CGAF, since such resultant peptides inhibit secretion without the necessity for the preincubation step. At the present time, neither the nature nor the metabolism of this or these peptides, nor the nature of the enzymes responsible for the formation of these peptides are known. The active peptide or peptides may be formed by CGA cleavage at dibasic sites but this awaits proof. Thus CGA of the chromaffin granule would be a prohormone, a precursor of one or several peptides yet to be characterized which would play a regulatory role in catecholamine secretion, and thus in perturbed homeostasis in stress situations.
CHROMOGRANIN A OF THE ADRENAL MEDULLA OF OTHER SPECIES
Antibodies against CGA of bovine adrenal medullary chromaffin granules can be used to demonstrate the strict localization of CGA in the granules of bovine chromaffin cells (Fig. 3) . These antibodies have also been shown to detect CGA of chromaffin granules of other species; CGA appears to be a molecule the structure of which has been highly conserved during evolution, a fact confirmed by studies of its sequence. Chromogranin A of human chromaffin cells CGA of human adrenal medullary chromaffin granules has been characterized by immunoblots (Lloyd & Wilson, 1983; Hagn et al., 1986a; Schober et al., 1987) . It migrates as a doublet of apparent molecular masses 76 and 78 kDa, and a component with a slightly lower molecular mass also reacts with anti-CGA sera. It appears that CGA of human chromaffin granules is not degraded to the same extent as that of bovine adrenal chromaffin granules. Partial (Kruggel et al., 1985) and total (Konecki et al., 1987) primary sequences of CGA from human pheochromocytomas (a tumour of the adrenal medulla) are identical. Human CGA is a protein of 439 amino acids ( Fig. 1) Fig. 1 ). The nucleotide sequence of human cDNA as reported by Helman et al. (1988) is 86 % identical with that of bovine CGA cDNA. The sequence determined by Konecki et al. (1987) differs by 2 % from that reported by Helman et al. (1988) . Recently, the human CGA gene has been localized on chromosome 14 (Murray et al., 1987 Chromogranin A of rat chromaffin cells The CGA of rat chromaffin cells is not the major protein of secretory granules. The protein has a higher apparent molecular mass (80 kDa) than that of the bovine chromaffin cell CGA (Hutton et al., 1985; Rosa et al., 1985) . have shown that CGA isolated from rat pheochromocytomas has a molecular mass of 86 kDa.
lacangelo et al. (1988a) established the primary structure of rat pre-CGA from the nucleotide sequence of an adrenal medullary cDNA clone (Fig. 1) . This cDNA encodes for a protein of 466 amino acids (including the hydrophobic signal sequence of 18 amino acids which is 830 homologous with the corresponding bovine signal peptide). The actual molecular mass of the protein, such as can be deduced from its cDNA, is 50.2 kDa. Comparison of the primary sequences of rat and bovine CGA reveals similar features. Pairs of dibasic amino acids are present in both proteins, seven of the ten pairs having identical positions. The C-and N-terminal ends are highly conserved in the two molecules. Rat CGA possesses two potential N-linked glycosylation sites.
CGA levels in rat adrenal medullas have been determined in vivo after nervous stimulation (Sietzen et al., 1987) . When rats are treated with insulin or reserpine, CGA levels remain slightly below control levels. After hypophysectomy, CGA is reduced to low levels, and this is not compensated by new synthesis. This observation appears to be confirmed by measurements of CGA mRNA levels. Splanchnic nerve activation by insulin treatment in vivo has no effect on CGA mRNA levels, but in contrast, a significant reduction is observed after hypophysectomy. These data would tend to suggest that glycocorticoids regulate the expression of CGA in rat chromaffin cells at a pre-translational step (FischerColbrie et al., 1988; lacangelo et al., 1988a) . Chromogranin A in chromaffin cells of other vertebrates Rieker et al. (1988) showed that chromaffin cells or tissues from sheep, pig, horse, guinea-pig, chicken, mouse and from frog contain one or several proteins recognized by antibodies against bovine CGA. However, variations in the immunostaining patterns are observed in all species investigated. Analysis by immunoblots reveals a strongly immunoreactive band of 75 kDa (sometimes a doublet) corresponding to native CGA. In contrast, the profile and staining intensity of endogenous degradation products significantly vary from one species to another. A band that could correspond to proteoglycan-CGA is detected in some but not all species. The process of CGA degradation seems to exist in most species studied and its significance is probably the same as that proposed for bovine CGA.
CHROMOGRANIN A IN OTHER TISSUES
Recent studies have shown that the secretory vesicles of a large variety of cells, namely endocrine and nerve cells, contain proteins similar to CGA. The protein has been detected in these tissues (Tables 1 and 2) (Cohn et al., 1982) . The presence of anti-CGA immunoreactivity in parathyroid granules has subsequently been confirmed by other groups (Nolan et al., 1985; Lassmann et al., 1986; Hearn, 1987) . Purified SP-I from bovine parathyroids consists of at least two glycoproteins of nearly similar size (72 and 70 kDa) The difference in size might be accounted for by their carbohydrate composition. SP-I contains about 30 acidic amino acid residues and has an isoelectric pH of 4.5. Comparison of the peptides produced from bovine SP-I and CGA by chemical and enzymic hydrolysis confirms the homology of these two proteins (Hamilton et al., 1986) . Ahn et al. (1987) , who have established the primary structure of bovine SP-I (Fig. 1) (Seidah et al., 1987) . These authors suggest that the protein SP-I might play an important role as a regulator of post-translational processing of prohormones. Thyroid gland. CGA has been detected in C cells of both the thyroid gland and in tumours derived from them (O'Connor et al., 1983a; Cohn et al., 1984; Rindi et al., 1986; Hearn, 1987; Schmid et al., 1987) , although other studies have not confirmed these observations Lassmann et al., 1986 ). CGA appears to be localized in regions containing calcitonin-positive cells. CGA purified from C cells of human tumours has a molecular mass of 78 kDa. Deftos et al. (1986) isolated from human thyroid carcinomas a mRNA of about 2300 bases which codes for a 72 kDa protein immunoreactive with anti-CGA antibodies.
Endocrine pancreas. Anti-CGA immunoreactivity has been demonstrated in endocrine pancreas by numerous authors (O'Connor et al., 1983a; Cohn et al., 1984; Wilson & Lloyd, 1984; Varndell et al., 1985) . However, contradictory results have been published on the types of endocrine cells containing CGA. The data of Ehrhart et al. (1986) considerably clarify the previous results. These authors analysed in detail the cellular and subcellular distribution of CGA in bovine pancreatic islets of Langerhans. Anti-CGA immunoreactivity was detected in cells producing insulin, glucagon and somatostatin. Ultrastructural studies using an immunogold technique show that CGA-like immunoreactivity was confined exclusively to hormone-containing secretory granules. However, while the hormones are principally localized in the central part of vesicles, CGA is found essentially at the periphery (Ehrhart et al., 1986) . This localization, which is peculiar to CGA, has also been observed in human pancreatic islets (Hearn, 1987) , but its significance is not clear. Studies on the localization of CGA in the endocrine pancreas of a dozen mammalian species demonstrate that, apart from a few exceptions, all endocrine pancreatic cells of these mammals are immunoreactive (Grube et al., 1986) . The A cells are the most immunoreactive; nevertheless, each species has its own pattern of CGA-immunoreactive cell types.
Analysis of the CGA of bovine endocrine pancreas by electrophoresis shows that the major immunoreactive band migrates identically to bovine adrenal medullary CGA . Immunoblotting also reveals the presence of an additional species migrating more slowly than the 75 kDa CGA (proteoglycan-CGA). Besides this, an immunoreactive species with a lower molecular mass than CGA is observed, which is probably a degradation product. These data are in good agreement with results obtained on human pancreas (Hagn et al., 1986a) , but disagree with those of Hutton et al. (1985 Hutton et al. ( , 1987a on rat pancreas. These authors isolated from both normal rat pancreas and insulinomas a 20 kDa protein (called fl-granin) which is strongly recognized by antibodies against bovine chromaffin granule CGA and which is co-localized with insulin in rat pancreatic B cells. The sequence of ,l-granin has been determined ( Fig.   1 ) and it was found to be identical to the N-terminal sequence of rat adrenal medulla CGA (lacangelo et al., 1988a; Hutton et al., 1988) . It is probable that ,-granin is a proteolytic fragment of CGA solely expressed in rat endocrine pancreas. 'Pulse-chase' experiments in rat insulinomas show that /3-granin derives from a precursor which has been found to have a molecular mass (80-100 kDa), peptide map and immunoreactivity identical to those of the native CGA in rat 'adrenal medulla. This precursor appears to be rapidly converted soon after its passage through Golgi apparatus into a stable 20 kDa protein after initial cleavage by a calcium-dependent endoprotease at one of its pairs of basic amino acids. The precursor is not a stable constituent of rat endocrine pancreatic cells; rather ,J-granin, which is more stable, seems to be the major component of secretory granules of rat insulinomas (Hutton et al., 1987a,b) . The cDNA corresponding to the mRNA coding for the precursor form of rat insulinoma fl-granin has a sequence identical to that of rat adrenal medulla CGA (Hutton et al., 1988) .
Recently, Tatemoto et al. (1987) purified a peptide of 49 amino acids from porcine endocrine pancreas, called pancreastatin. The primary structure of porcine CGA, deduced from the sequence of an adrenal medulla CGA cDNA clone (Fig. 1) shows that CGA is the potential precursor of porcine pancreastatin (Tacangelo et al., 1988b) . The CGAs of rat (Hutton et al., 1988; Iacangelo et al., 1988a) , ox (Eiden, 1987) and man (Konecki et al., 1987; Helman et al., 1988) contain a -sequence which according to species, is 59-71 % identical with that of porcine pancreastatin. The observed differences are due to species variations, thus strongly suggesting that pancreastatin could be derived from CGA itself rather than a similar protein.
The primary structure of a peptide found in certain human endocrine pancreatic tumours (pancreatic glucagonoma) has been determined after its identification by a specific antibody raised against porcine pancreastatin. The sequence ofthis human 28 amino-acid pancreastatin-like peptide (Fig. 1 ) is 750 homologous with that of porcine pancreastatin (Sekiya et al., 1988) .
Pancreastatin inhibits the rapid phase of insulin release when the rat pancreas is stimulated with glucose (Tatemoto et Efendic et al., 1987) ; it also seems capable of inhibiting acid secretion from rat gastric parietal cells (Delvalle et al., 1987) . This result supports the idea that CGA might be the precursor of a group of peptides regulating the activity of certain endocrine cells (see also Simon et al., 1988 (O'Connor et al., 1983b; Somogyi et al., 1984; Lassmann et al., 1986) . A detailed study of the anterior lobe of several species (ox, sheep, rat, human) reveals the presence of a CGA-like protein in gonadotropin-and thyrotropin-producing cells. Somatotropinsecreting cells are weakly stained in the ox and sheep, but not at all in man and rat (O'Connor et al., 1983b; Cohn et al., 1984; Lloyd et al., 1985; Rundle et al., 1986) . The pituitary protein recognized by antiserum against chromaffin cell CGA has a molecular mass and an isoelectric pH identical to those of the adrenal medulla CGAs of the species concerned (Somogyi et al., 1984; Rosa et al., 1985; Hagn et al., 1986a ), although O'Connor (1983 and Nolan et al. (1985) reported different data. The nucleotide sequences of the CGA cDNAs from the adrenal medulla and pituitary are quasi-identical and analysis of genomic DNA suggests that pituitary and adrenal CGA are products of the same gene (Ahn et al., 1987 Rindi et al., 1986; Grube et al., 1987; Hearn, 1987; Qian et al., 1988) . The enterochromaffin cells of the small intestine are very intensely immunostained (man, ox). In the same species, cells of the digestive epithelium which secrete entero-glucagon and gastrin also react with anti-CGA sera. In all cases, immunoreactivity is restricted to the secretory vesicles.
Other non-nervous tissues. Anti-CGA immunoreactivity has also been detected in rat and bovine spleen, thymus (lymphocytes are not stained) and lymph nodes (Nolan et al., 1985; Hogue Angeletti & Hickey, 1985) . The presence of CGA in lymph organs thus demonstrates the relationship between the immune and endocrine systems. The presence of CGA in cat and porcine Merkel cells, granular cells of the epithelium the function of which is not yet known, has been reported by Gauweiler et al. (1988) . The immunoreactivity of these cells depends on the developmental stage of the animal. Lauweryns et al. (1987) demonstrated immunoreactivity towards anti-CGA in monkey lung and also in the lung of human foetus. Weiler et al. (1987) found that the antigen responsible for the immunostaining from human bronchial carcinoids is a protein of molecular mass identical to that of CGA from chromaffin cells. Immunoblots revealed, in addition, large amounts of a proteoglyan-CGA. More recently, Murray et al. (1988) described the co-regulation of secretion and cytoplasmic CGA mRNA in a cell line derived from a human lung cancer. In this cell line, treatment of cells with phorbol 12-myristate 13-acetate results in a significant dose-dependent increase of CGA secretion and of CGA-specific cytoplasmic mRNA level.
Reiker et al. (1988) characterized a protein of about 74 kDa which is present in an organ of the carp, the so-called 'head kidney', and in two endocrine glands of the lobster situated close together near the eye socket. This protein is recognized by antibodies against bovine chromaffin granule CGA. The demonstration of anti-CGA immunoreactivity in the ultimobranchial glands and in some other endocrine glands of the rainbow trout and coho salmon suggests a wide distribution of CGA very early in evolution. Chromogranin A in nervous cells and tissues CGA is present in the central and peripheral nervous system (Somogyi et al., 1984) . Anti-CGA immunoreactivity was detected throughout the brain (cerebral cortex, amygdala, cerebellum, locus coeruleus, hippocampus, basal ganglion, spinal cord). In spite of this wide distribution, the brain contains about 1000-fold less CGA than the adrenal medulla, the tissue in which CGA is most abundant (O'Connor & Frigon, 1984) . In the brain, CGA is found in noradrenergic neurons, in neurons containing enkephalins, dynorphin and neo-endorphin (Somogyi et al., 1984) and in cholinergic neurons (Somogyi et al., 1984; Volknandt et al., 1987) . However, these neurons are not systematically CGA-positive. O'Connor & Frigon (1984) showed that bovine brain CGA is most prominent in neuronal cytosol rather than in synaptosomal fractions which are rich in neurotransmitter storage vesicles. The 74 kDa CGA detected in mammalian brain extracts might be cleaved into non-immunoreactive peptides in nerve terminals. CGA mRNA is detectable in bovine striatum, and in the rat central nervous system the mRNAs have been detected in the cerebral cortex and in the hippocampus (lacangelo et al., 1 988a).
In 1969, Banks et al. noticed an antigen which was recognized by anti-CGA immune serum in noradrenergic vesicles of bovine splenic nerve. The CGA-like protein of bovine splenic nerve has recently been characterized (Neuman et al., 1984; Hagn et al., 1986b) : it has a molecular mass of 75 kDa and an isoelectric pH of 5.0.
CHROMOGRANIN A OF INVERTEBRATES
The ciliated protozoan Paramecium tetraurelia produces secretory granules (trichocysts) which liberate acidic proteins. Antibodies against bovine chromaffin granule CGA and those produced against chemically synthesized CGA-related peptides recognize certain proteins of trichocysts. Conversely, antibodies directed against trichocyst proteins cross-react with bovine chromaffin granule CGA. The anti-CGA antibodies recognize trichocyst proteins of molecular masses between 15 and 25 kDa. Larger proteins of 53 and 49 kDa which are also recognized in crude extracts of Paramecium tetraurelia could correspond to unprocessed precursors of the 15-25 kDa proteins found in mature trichocysts (Peterson et al., 1988) . Other data confirm the relationship between certain proteins of Paramecium tetraurelia and mammalian CGA: Paramecium mRNAs hybridize with bovine CGA cDNA clone (Peterson et al., 1988) .
CHROMOGRANIN A AND NEUROENDOCRINE TUMOURS
Tumours of neuroendocrine tissues may be detected by measurement of plasma CGA levels. In general, the CGA concentration is relatively stable in the plasma of normal individuals but increases dramatically in patients with certain tumours of endocrine origin. The rise in plasma CGA levels reflects the increased secretion rate of peptides or hormones by (neuro)endocrine tumour tissues. The demonstration of a rise in plasma CGA levels in patients with certain endocrine tumours could be of great clinical value, particularly for the early diagnosis of these tumours (O'Connor & Bernstein, 1984; but such an approach should be developed more systematically.
CONCLUSIONS
Twenty years ago, when chromogranin A was described for the first time, it was thought that this protein was limited to chromaffin granules of the adrenal medulla. Since this time, it has become clear that it is widely distributed in mammalian endocrine and neuroendocrine tissues. It is also found in certain tissues of the lower vertebrates, such as shellfish, demonstrating its early appearance during evolution; it seems, in addition, to be highly conserved. 
